Cite
HARVARD Citation
Marcellin, P. et al. (2016). Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa‐2a combination therapy for chronic hepatitis B. Alimentary pharmacology & therapeutics. 44 (9), pp. 957-966. [Online].